Adam Laponis serves as the Chief Financial Officer (CFO) at Twist Bioscience Corp, a leading synthetic biology and genomics company. In his role, Laponis is responsible for overseeing the financial operations and strategy of the company, ensuring its continued growth and success in the competitive biotechnology industry. His leadership has been instrumental in guiding Twist Bioscience through various stages of development, from scaling up operations to expanding its product offerings and market reach. Prior to joining Twist Bioscience, Laponis held several high-level financial positions at notable companies within the life sciences sector. He spent over a decade at Illumina, Inc., where he progressed through various roles, ultimately serving as the Vice President of Finance. During his tenure at Illumina, Laponis played a key role in driving the company's financial performance and supporting its expansion into new markets. His experience in the industry has equipped him with a deep understanding of the financial challenges and opportunities faced by biotechnology firms. Laponis's achievements extend beyond his corporate roles. He is recognized for his strategic financial planning and his ability to foster strong relationships with investors and stakeholders. Under his guidance, Twist Bioscience has successfully navigated the complexities of the biotech market, securing funding and partnerships that have propelled the company forward. Laponis holds a Bachelor of Science in Business Administration from the University of Southern California and an MBA from the University of California, Los Angeles. His educational background, combined with his extensive professional experience, makes him a vital asset to Twist Bioscience as it continues to innovate and grow in the field of synthetic biology.